NCT03040401 2017-12-19
A Study of HDC/IL-2 Treatment in Chronic Myelomonocytic Leukemia (CMML)
Vastra Gotaland Region
Phase 1/2 Unknown
Clinical Trials
3 trialsNCT01347996 2017-11-29
Maintenance Therapy With Ceplene® (Histamine) and IL-2 on Immune Response and MRD in Acute Myeloid Leukemia
Cytovia, Inc.
Phase 4 Completed
NCT00003991 2013-11-06
Interleukin-2 Plus Histamine Dihydrochloride in Treating Patients With Acute Myeloid Leukemia
National Cancer Institute (NCI)
Phase 3 Completed